New research reveals that individuals who come off popular slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who halt traditional lifestyle programs.
Published data in a prominent health publication demonstrates that while obese individuals frequently drop a large proportion of their body weight while using the jabs, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing these drugs should be informed of the danger of fast rebound weight gain when the treatment ends," cautioned expert Dr. Susan Jebb.
This pace of regain implies a return to pre-treatment weight in about 18 months.
Weighing Approaches
The study, which reviewed 37 of studies involving thousands of patients, compared the outcomes of these new drugs with other pills.
Researchers note that individuals who lose weight through dieting typically see a less rapid weight regain—approximately 0.1 kg a month—after stopping.
Explaining the Fast Regain
Nutrition scientists believe the mode of action of the drugs explains the amplified regain.
These medications mimic a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Artificially providing the hormone concentrations far above than normal may cause the body to generate a reduced amount of its endogenous hormone, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this GLP-1 'fix' results in appetite is uncontrolled, making binge eating far more likely."
An Ongoing Issue?
Medical guidelines suggest the jabs for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Professionals say that, due to the high risk of weight regain, the treatment might need to be ongoing.
This perspective is supported by drug manufacturers, who say that the findings "emphasize the persistent nature of obesity," comparing it to managing diseases like hypertension.
User Testimonies
Individuals who have discontinued the medication explain a intense return of cravings.
"It was like a trigger that goes on and I was suddenly extremely hungry," described one woman.
The struggle is compounded if individuals have not adopted permanent dietary or behavioural modifications during treatment.
Growing Adoption
Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.
- Adoption is greater among females compared to men.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion access the drugs through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while the jabs are effective tools for weight loss, they are not a magic fix and long-term success relies on combined lifestyle changes.
